nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Dyspepsia—Leflunomide—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Perflutren—Vomiting—Mometasone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Perflutren—Dry mouth—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Perflutren—Sweating increased—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Perflutren—Feeling abnormal—Azathioprine—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Perflutren—Rash—Mometasone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Asthenia—Captopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Dermatitis—Mometasone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Headache—Mometasone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Perflutren—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Fatigue—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Oedema—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Pruritus—Captopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Perflutren—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Perflutren—Pain—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Perflutren—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Perflutren—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Perflutren—Shock—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Perflutren—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Perflutren—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Perflutren—Tachycardia—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Perflutren—Abdominal pain—Azathioprine—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Perflutren—Body temperature increased—Azathioprine—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Perflutren—Skin disorder—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Perflutren—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Perflutren—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Perflutren—Diarrhoea—Captopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Perflutren—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Perflutren—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Perflutren—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Perflutren—Feeling abnormal—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Perflutren—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Perflutren—Fatigue—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Perflutren—Nausea—Mometasone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Perflutren—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Perflutren—Pain—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Perflutren—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Perflutren—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Perflutren—Cough—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Perflutren—Hypotension—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Perflutren—Dizziness—Captopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Perflutren—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Perflutren—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Perflutren—Urticaria—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Perflutren—Abdominal pain—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Perflutren—Body temperature increased—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Perflutren—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Perflutren—Hypersensitivity—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Perflutren—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Perflutren—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Perflutren—Paraesthesia—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Perflutren—Vomiting—Captopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Perflutren—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Perflutren—Dyspnoea—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Perflutren—Rash—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Perflutren—Dermatitis—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Perflutren—Headache—Captopril—systemic scleroderma	0.000999	0.000999	CcSEcCtD
Perflutren—Dyspepsia—Lisinopril—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Perflutren—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Perflutren—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Perflutren—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Perflutren—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Perflutren—Eosinophilia—Methotrexate—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Perflutren—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Perflutren—Fatigue—Lisinopril—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Perflutren—Shock—Mycophenolate mofetil—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Perflutren—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Perflutren—Hypersensitivity—Leflunomide—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Perflutren—Pain—Lisinopril—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Perflutren—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Perflutren—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Perflutren—Bradycardia—Prednisone—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Perflutren—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Perflutren—Diarrhoea—Azathioprine—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Perflutren—Haemoglobin—Prednisone—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Perflutren—Nausea—Captopril—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Perflutren—Haemorrhage—Prednisone—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Perflutren—Asthenia—Leflunomide—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Perflutren—Feeling abnormal—Lisinopril—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Perflutren—Pruritus—Leflunomide—systemic scleroderma	0.000929	0.000929	CcSEcCtD
Perflutren—Connective tissue disorder—Prednisone—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Perflutren—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Perflutren—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Perflutren—Dizziness—Azathioprine—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Perflutren—Asthenia—Mycophenolic acid—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Perflutren—Diarrhoea—Leflunomide—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Perflutren—Urticaria—Lisinopril—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Perflutren—Abdominal pain—Lisinopril—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Perflutren—Body temperature increased—Lisinopril—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Perflutren—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Perflutren—Pruritus—Mycophenolic acid—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Perflutren—Vomiting—Azathioprine—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Perflutren—Eye disorder—Prednisone—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Perflutren—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Perflutren—Rash—Azathioprine—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Perflutren—Dermatitis—Azathioprine—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Perflutren—Flushing—Prednisone—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Perflutren—Headache—Azathioprine—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Perflutren—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Perflutren—Dizziness—Leflunomide—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Perflutren—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Perflutren—Angiopathy—Prednisone—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Perflutren—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Perflutren—Immune system disorder—Prednisone—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Perflutren—Pain—Mycophenolate mofetil—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Perflutren—Arrhythmia—Prednisone—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Perflutren—Vomiting—Leflunomide—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Perflutren—Hypersensitivity—Lisinopril—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Perflutren—Dizziness—Mycophenolic acid—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Perflutren—Rash—Leflunomide—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Perflutren—Dermatitis—Leflunomide—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Perflutren—Nausea—Azathioprine—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Perflutren—Headache—Leflunomide—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Perflutren—Erythema—Prednisone—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Perflutren—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Perflutren—Asthenia—Lisinopril—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Perflutren—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Perflutren—Pruritus—Lisinopril—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Perflutren—Vomiting—Mycophenolic acid—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Perflutren—Rash—Mycophenolic acid—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Perflutren—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Perflutren—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Perflutren—Headache—Mycophenolic acid—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Perflutren—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Perflutren—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Perflutren—Nausea—Leflunomide—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Perflutren—Vision blurred—Prednisone—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Perflutren—Diarrhoea—Lisinopril—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Perflutren—Ill-defined disorder—Prednisone—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Perflutren—Agitation—Prednisone—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Perflutren—Angioedema—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Perflutren—Dizziness—Lisinopril—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Perflutren—Nausea—Mycophenolic acid—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Perflutren—Malaise—Prednisone—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Perflutren—Vertigo—Prednisone—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—systemic scleroderma	0.000737	0.000737	CcSEcCtD
Perflutren—Syncope—Prednisone—systemic scleroderma	0.000737	0.000737	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Perflutren—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Perflutren—Loss of consciousness—Prednisone—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Perflutren—Vomiting—Lisinopril—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Perflutren—Rash—Lisinopril—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Perflutren—Convulsion—Prednisone—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Perflutren—Dermatitis—Lisinopril—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Perflutren—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Perflutren—Hypertension—Prednisone—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Perflutren—Chills—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Perflutren—Headache—Lisinopril—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Perflutren—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Perflutren—Myalgia—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Perflutren—Arthralgia—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Perflutren—Discomfort—Prednisone—systemic scleroderma	0.000691	0.000691	CcSEcCtD
Perflutren—Erythema—Methotrexate—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Perflutren—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Perflutren—Nausea—Lisinopril—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Perflutren—Anaphylactic shock—Prednisone—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Perflutren—Oedema—Prednisone—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Perflutren—Back pain—Methotrexate—systemic scleroderma	0.000664	0.000664	CcSEcCtD
Perflutren—Shock—Prednisone—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Perflutren—Nervous system disorder—Prednisone—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Perflutren—Tachycardia—Prednisone—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Perflutren—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Perflutren—Skin disorder—Prednisone—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisone—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Perflutren—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Perflutren—Rash—Mycophenolate mofetil—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Perflutren—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Perflutren—Headache—Mycophenolate mofetil—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Perflutren—Malaise—Methotrexate—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Perflutren—Vertigo—Methotrexate—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Perflutren—Paraesthesia—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Perflutren—Cough—Methotrexate—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Perflutren—Convulsion—Methotrexate—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Perflutren—Dyspepsia—Prednisone—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Perflutren—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Perflutren—Myalgia—Methotrexate—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Perflutren—Chest pain—Methotrexate—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Perflutren—Fatigue—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Perflutren—Discomfort—Methotrexate—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Perflutren—Feeling abnormal—Prednisone—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Perflutren—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Perflutren—Urticaria—Prednisone—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Perflutren—Body temperature increased—Prednisone—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Perflutren—Abdominal pain—Prednisone—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Perflutren—Hypotension—Methotrexate—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Perflutren—Hypersensitivity—Prednisone—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Perflutren—Fatigue—Methotrexate—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Perflutren—Asthenia—Prednisone—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Perflutren—Pain—Methotrexate—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Perflutren—Pruritus—Prednisone—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Perflutren—Diarrhoea—Prednisone—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Perflutren—Urticaria—Methotrexate—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Perflutren—Dizziness—Prednisone—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Perflutren—Vomiting—Prednisone—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Perflutren—Rash—Prednisone—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Perflutren—Dermatitis—Prednisone—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Perflutren—Headache—Prednisone—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Perflutren—Asthenia—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Perflutren—Nausea—Prednisone—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Perflutren—Pruritus—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Perflutren—Dizziness—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Perflutren—Vomiting—Methotrexate—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Perflutren—Rash—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Perflutren—Headache—Methotrexate—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Perflutren—Nausea—Methotrexate—systemic scleroderma	0.000333	0.000333	CcSEcCtD
